Dr. Khalid is an associate professor of medicine at Albert Einstein College of Medicine/Montefiore Medical Center. She is board-certified in both internal medicine and addiction medicine. Dr. Khalid’s interests lie in the judicious use of long-term opioid therapy and treatment of substance use disorders. She has developed and co-leads an innovative teaching clinic embedded in primary care where residents get an experiential medical education in long-term opioid therapy and patients receive guideline-adherent care. She is an eConsultant for opioid management of ambulatory patients at Montefiore. As a buprenorphine site champion, she supervises integration of treatment of opioid use within primary care. She is also a member of several working groups to improve treatment of substance use disorders in the inpatient setting at Montefiore.

1.     Tu JV, Khalid L, Donovan LR, Ko DT; Canadian Cardiovascular Outcomes Research Team/Canadian Cardiovascular Society Acute Myocardial Infarction Quality Indicator Panel. Indicators of quality of care for patients with acute myocardial infarction. Canadian Medical Association Journal 2008;179:909-15.

2.     Tu JV, Nardi L, Fang J, Liu J, Khalid L, Johansen H; Canadian Cardiovascular Outcomes Research Team. Nationwide trends in mortality and hospitalization rates for acute myocardial infarction, heart failure and stroke, 1994 to 2004. Canadian Medical Association Journal 2009; 180:E118-25.

3.     Liebschutz JM, Khalid L. Treating chronic pain: What is left out of the patient encounter. European Journal of Pain 2014;18:751-2.

4.     Khalid L, Liebschutz JM, Xuan Z, Dossabhoy S, Kim Y, Crooks D, Shanahan C, Lange A, Heymann O, Lasser KE. Adherence to prescription opioid monitoring guidelines among residents and attending physicians in the primary care setting. Pain Medicine 2014;16:480-7.

5.     Lange A, Lasser KE, Xuan Z, Khalid L, Beers D, Heymann OD, Shanahan CW, Crosson J, Liebschutz JM. Variability in opioid prescription monitoring and evidence of aberrant medication taking behaviors in urban safety-net clinics. Pain 2015;156:335-40.

6.     Sohler NL, Starrels JL, Khalid L, Bachuber MA, Arnsten JH, Nahvi S, Jost J, Cunningham CO. Cannabis use is associated with lower odds of prescription opioid analgesic use among HIV-infected individuals with chronic pain. Substance Use and Misuse 2018;17:1-6.

7.   Khalid L, Roth R, Zhang C, Burkenroad A, Carrozzi G, Starrels J. Guideline adherence and reasons for recommending dose reduction in a primary care based opioid management clinic. Journal of Opioid Management Nov 2021.

8.   Cunningham C, Khalid L, Deng Y, Torres-Lockhart K, Masyukova M, Thomas S, Zhang C, Lu T. A comparison of office-based buprenorphine treatment outcomes in a Bronx community clinic before versus during the COVID-19 pandemic. Journal of Substance Abuse. 2022. Apr;135:108641. doi: 10.1016/j.jsat.2021.108641. 

9.  RIkin S, Perez H, Zhang C, Khalid L, Groeger J, Deng Y, Starrels J. Changes in outpatient opioid prescribing during the COVID-19 pandemic: An interrupted time series analysis. Journal of Primary Care and Community Health, January 2022. doi:10.1177/2150131922107692

10. Khalid L, Cunningham C, Deng Y, Masyukova M, Bumol J, Valle A, Zhang C, Lu T. Cascade of care for office-based buprenorphine treatment I Bronx community clinics. Journal of Substance Abuse. April 2022. https://doi.org/10.1016/j.jsat.2022.108778